Publications found:
54,468
Sort by:
China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)
US$ 1,990.00
... forecast period By therapy type, the China anti-cancer drugs market is segmented into chemotherapy, targeted therapy, hormonal therapy and others. Chemotherapy and targeted therapy together held the major share of China cancer drugs market. Company ...
August 2018
-
China In–Vitro Diagnostics (IVD) Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)
US$ 1,490.00
... of China In–Vitro Diagnostics (IVD) Market. By Segment – Immunoassay and Clinical Chemistry dominates the China IVD Market The report studies the market of the following In–Vitro Diagnostics (IVD) segments: Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self ...
August 2018
-
Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] By Countries (United States, Canada, United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway, Switzerland, India, China, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, Australia, New Zealand)
US$ 1,590.00
... organizations & biotechnology. Renub Research latest study report “Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] By Countries (United States, Canada, United Kingdom, France ...
July 2018
-
Global Blood screening Market Research and Forecast 2018-2023
US$ 3,600.00
... : Global Blood screening Market is segmented on the basis of various regions and below mentioned segments: Global Blood screening Market Research and Analysis, By Screening technology Global Blood screening Market Research and Analysis, By End users Global Blood screening Market ...
July 2018
-
Molecular Diagnostics Market, Global Forecast by Application, Technology, End User, Regions, Companies
US$ 1,790.00
... in no time. Renub Research report titled “Molecular Diagnostics Market, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated ...
July 2018
-
2018 US Coagulation Testing Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts - Hospitals, Commercial Laboratories, POC Locations - Competitive Landscape, Emerging Technologies, Instrumentation Review
US$ 8,500.00
... and reagent suppliers. Potential market entry barriers and risks. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, ... established and emerging procedures. Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other ...
July 2018
455 pages
Global Cancer Gene Therapy Market Research and Forecast 2018-2023
US$ 3,600.00
... . MARKET SEGMENTATION: Global Cancer gene therapy market is segmented on the basis of regional outlook and following segments: Global Cancer gene therapy Market Research and Analysis, By Therapy Global Cancer gene therapy Market Research and Analysis, By End Users Global Cancer gene therapy Market Research ...
July 2018
-
Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators
US$ 1,690.00
Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators This product consists of four reports in pdf ... include compilations of currently active projects in research and development of immunomodulators in immuno-oncology. In addition, each report lists company-specific R&D pipelines of ...
July 2018
455 pages
2018 Italy Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Italy ...
June 2018
570 pages
2018 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 9,800.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the US cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
June 2018
620 pages
2018 France Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in France ...
June 2018
585 pages
2018 Germany Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Germany ...
June 2018
585 pages
2018 Japan Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 8,800.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Japan ...
June 2018
590 pages
2018 Spain Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Spain ...
June 2018
565 pages
2018 UK Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the UK cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
June 2018
565 pages
2018 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 19,700.00
... identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the ... universe of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business Opportunities and Strategic ...
June 2018
820 pages
Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023
US$ 3,390.00
... in the market: Market Penetration: Comprehensive information on the top 15 players in the microbiology testing/clinical microbiology market. The report analyzes the microbiology testing market by application and region; and the clinical microbiology market by product ...
June 2018
224 pages
Hepatitis C: Drug Development Pipeline Study, H2 2018
US$ 1,350.00
... cirrhosis or liver cancer. Hepatitis C pipeline comprises of 85 active drugs under active development as of June 2018. Of these, 16 drugs are in Phase 1 and 19 drugs in phase 2. Only 4 drugs progressed to Phase 3. Further ...
June 2018
150 pages
Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
US$ 24,500.00
... Triglycerides, Troponin, Uric Acid. Therapeutic Drug Monitoring (TDM) Amikacin, ... marketing tactics, and new products in R&D. Market Segmentation Analysis Comprehensive market segmentation analysis, including review of the market ... emerging clinical chemistry and immunodiagnostic tests. Review of current ...
June 2018
1115 pages